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Abstract
Background: More than 2.5 million people develop pressure ulcers (PUs) annually. PUs
cost the U.S. $9.1-11.6 billion per year and add about $43,180 to a hospital stay. The Centers for
Medicare Medicaid Services (CMS) stopped reimbursement for hospital-acquired pressure ulcers
(HAPUs). Documentation of PUs must indicate if they are present on admission (POA) and
include accurate stages and treatment plan of PUs.
Aims/Objectives: To use Digital Imaging platform using Tissue Analytics (TA) along
with the standard care protocol. The objectives of this study were to (1) Improve identification of
PUs, (2) Increase accuracy of PU staging and (3) Improve documentation of PUs.
Methods: This quality improvement study included a convenience sample of 55 adults
with HAPUs. NDNQI measures and data from chart audits were collected. Demographic
information, POAs and HAPUs, and Braden scores were analyzed along with a staff attitude’s
survey.
Results: 5.11 POAs per 1000 patient admissions (95% CI = [3.33, 7.84]) preinterventions, and 2.25 POAs per 1000 patient admissions (95% CI = [1.17, 4.33]) postintervention. POA prevalence rate remained about the same.
Documentation of HAPU stages (χ2 (5) = 9.823, p = 0.059) was not statistically
significant but documentation of POA staging was significant (χ2 (6) = 16.395, p = 0.003). The
number of DTIs increased while Unstageable PUs decreased post-intervention. Braden score=
14.52 (SD = 3.65) pre-intervention and 14.56 (SD = 2.55) post-intervention. Staff Attitudes’
survey scores reflected poor PU prevention attitude (33.36).
Conclusions:

Digital imaging Platform using TA along with the standard protocol did

not significantly improve the identification of POAs nor rate of documentation. Documented
difference in staging was noted. Also, improved quality of documentation was noticed.

Implementing a Digital Imaging Protocol
6

Introduction
The practice site of this DNP project aimed to improve the identification of pressure
ulcers (PUs) that are present on admission (POA) from those that are hospital-acquired pressure
ulcers (HAPUs); and, also improve documentation of PUs. In 2008, the Centers for Medicare
and Medicaid Services (CMS) denied reimbursements for hospital-acquired conditions or HACs
(CMS, 2015). Additionally, CMS implemented a HAC reduction program in 2014 that used
performance scores to determine reimbursement payments to organizations (CMS, 2020).
According to these policies, hospitals would lose reimbursement for Stages III and IV PUs that
were hospital-acquired (Rogers, 2013). POAs do not come with those penalties; however, if a PU
is POA but not documented, it is still considered a hospital-acquired condition and not
reimbursable (Rogers, 2013). Patient safety concerns, as well as a loss of reimbursement,
increases the incentive to accurately identify and document PUs that are POA (Roger, 2013). The
current organization was using a bundled care program which included the following standard
interventions: (1) Skin assessment of all patients upon admission, (2) Daily skin reassessment,
(3) Daily skin inspections, (4) Moisture management on the skin, (5) Optimization of nutrition
and hydration, and (6) Minimization of pressure (IHI, 2019)). They were also using the Braden
scale risk assessment tool, “4 eyes” assessment (pairing 2 RNs to assess a patient), monthly
wound rounding, specialized beds, and wound barriers. However, the site implemented a digital
imaging platform using tissue analytics. With this technology, a smartphone equipped with
HIPAA compliant tissue analytics software was used to capture 3D images of wounds, analyze
the image, and wirelessly download the image and measurements to the hospital’s EMR system.
The technology was used during the admission assessment and subsequent skin assessments to
capture any skin abnormalities present. The purpose of the technology was to improve
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identification of POAs on admission, improve the documentation of PU staging, improve the
accuracy of PU documentation in order to improve patient quality of care.
Background and Significance
According to the National Pressure Ulcer Advisory Panel and the European Pressure
Ulcer Advisory Panel (NPUAP/EPUAP, 2014), a pressure ulcer (PU) is “a localized injury to the
skin and/or underlying tissue, usually over a bony prominence, resulting from sustained pressure
(including pressure associated with shear).” However, some PUs result from external pressure
from medical devices and, therefore, do not completely fit this definition (Pittman et al., 2015).
Additionally, in April 2016, the National Pressure Ulcer Advisory Panel (NPUAP) revised the
NPUAP Injury Staging System to replace the term “pressure ulcer” with “pressure injury” to
reflect injuries to both intact and ulcerated skin (Joint Commission, 2014). However, for this
project, the term “pressure ulcers” will be used for consistency with resources, which have not
all adopted the term “skin injuries.” See Appendix C for PU stages.
Beal and Smith (2016) defined hospital-acquired pressure ulcers (HAPUs) as any PU
assessed on a patient after 24 hours of being admitted to the hospital that was not documented
upon admission. HAPUs occur at a rate of 1- 2.5 million annually in the United States (Meddings
et al., 2015) and affect patient outcomes, increase pain, loss of function, increase hospital length
of stay (LOS), increase patient readmissions, and increase patient mortality (Han et al., 2019).
According to Lyder et al. (2012), the LOS for those with PUs was 11.2 days compared to 4.8
days for those who did not have PUs. Additionally, more than 60,000 patients in the US die each
year as a direct result of PUs (AHRQ, 2014).
HAPUs are very costly and have a huge financial impact on organizations; they result in
healthcare costs from $9.1-$11 billion annually (AHRQ, 2014). The costs to heal a single ulcer
usually depends on the stage of the ulcer -the higher the stage, the higher the cost (Meddings et

Implementing a Digital Imaging Protocol
8

al., 2015). It has been estimated that the cost of treating Stage 1 PUs is just over $2,000; stage 2
from $3,000-$10,000; stage 3 from $5,900-$14,840 and stage 4 PUs can cost as much as
$18,730-21,410 (Leaf Healthcare, 2016). The cost of individual patient care can range from
$20,900 to $151,700 per pressure ulcer (AHRQ, 2014). Medicare estimated in 2007 that each
pressure ulcer added about $43,180 in costs to a hospital stay (AHRQ, 2014).
In October 2008, the Centers for Medicare & Medicaid Services (CMS), enacted a policy
that stopped reimbursement for stage III to IV HAPUs unless the ulcers were present on
admission (POA) (Mallah et al., 2015). Additionally, in October 2014, CMS implemented a 1%
reimbursement penalty to hospitals with the lowest scores for hospital-acquired condition rates
(Padula et al., 2015). The financial incentives seemed to influence hospitals to increase their
efforts to prevent HAPUs (Padula, Gibbons, Valuck, et al., 2016). In a longitudinal study of
HAPU incidences collected from 55 hospitals from 2007 to 2012, Padula, Gibbons, Valuck, et al.
(2016) found that HAPU rates decreased significantly after enactment of the CMS nonpayment
policy.
HAPUs have become a major quality indicator for healthcare organizations and the rates
are measured and tracked by organizations for their safety reports and by national agencies. For
instance, the National Database of Nursing Quality (NDNQI) collects and tracks the PU and
HAPU prevalence rates from approximately 2000 participating facilities (Montalvo, 2007; Roe
& Williams, 2014). The rates are compared between similar-sized organizations and to the
national annual PU benchmark, which is currently 3.3% (Montalvo, 2007; Hillrom, 2019). An
organization may use this information to devise its own internal benchmark and process
improvements in order to improve their rates (VanGilder et al., 2008).
In order to successfully prevent HAPUs, a multidisciplinary, multidimensional,
customized, collaborative approach is needed (AHRQ, 2014) Once a patient is admitted to the
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hospital, the following strategies are implemented 1) A PU risk assessment usually via a risk
assessment tool (such as the Braden Scale or Norton Scale) and 2) Standard interventions are
completed. The comprehensive skin assessment is part of the standard intervention; each of these
factors will be discussed below:
Risk Assessment tools
The site of this DNP project currently uses the Braden Scale risk assessment tool (RAS)
(Appendix B). The Braden Scale (BS) is a commonly used RAS that identifies risk factors for
developing a PU and helps to plan care (AHRQ, 2014). The Braden Scale has established
reliability and validity and is made up of six subscales (sensory perception, moisture, activity,
mobility, nutrition, friction, and shear). Items of the scale are scored from 1-4 (1 for a low level
of functioning; 4 for the highest level or no impairment). Scores range from 6-23 with scores less
than 18 indicating an at-risk status; levels are further divided into mild, moderate, high risk
(AHRQ, 2019).
The BS showed good inter-rater reliability ranging from 83% to 99%) in multiple clinical
settings (Jackson, 2011). The sensitivity and specificity of the BS are high (0.83-1.00 and 0.640.90, respectively) when the cut-off point is a score of 16 (Jackson, 2011). For BS scores ranging
from 12-20, the sensitivity ranged from 29% to 93% and the specificity ranged from 67% to 97%
(Jackson, 2011).
Standard Interventions
Standard interventions are used as part of the multidimensional approach to prevent
HAPUs. According to the Institute for Healthcare Improvement (IHI, 2019), these standard PU
prevention interventions include the following:
(1) Conducting a PU admission assessment on all patients
(2) Reassessing risk for all patients daily
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(3) Inspecting skin daily
(4) Managing moisture on the skin
(5) Optimizing nutrition and hydration, and
(6) Minimizing pressure
Comprehensive Skin Assessment
A comprehensive skin assessment is part of the standard interventions and is extremely
important. See Appendix A for Comprehensive Skin Assessment Components. A comprehensive
skin assessment can 1) Identify factors that predispose a person to developing PUs, such as
excessively dry skin, moisture-associated skin damage, or certain skin conditions; 2) Identify
ulcers that are present on admission (POA); 3) Assist in risk stratification since patients with an
existing PU is at risk for developing additional PUs (AHRQ, 2014). In most hospital settings, a
comprehensive skin assessment should be performed on admission to the unit, daily, and upon
transfer and discharge (AHRQ, 2014). In some settings, a comprehensive skin assessment is
completed as frequently as every shift (AHRQ, 2014).
The DNP site was using the RAS with standard interventions in addition to a paired RN
(“4 eyes”) assessment, regular rounding by the wound team, and use of specialized beds and
barriers. However, POA identification issues and documentation challenges persisted and a
needs assessment demonstrated the need for additional interventions. Based on research and
studies of other hospital practices, the organization decided to integrate a digital imaging
platform using tissue analytics into their practice. With this technology, a smartphone equipped
with HIPAA compliant software captures a 3D image of a wound, automatically measures and
analyzes the wound, and calculates the wound dimension, perimeter, surface area, and tissue
composition (Tissue Analytics, 2019). The data flows wirelessly into major EMRs such as
Cerner (Tissue Analytics, 2019), which this organization currently uses.
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The tissue analytics (TA) platform has proven to be 40% more accurate than standard
ruler measurements (Tissue Analytics, 2019). It also saves time in documentation due to the
automatic uploading of the analyzations into the EMR (2019). And finally, with analysis from
measurements, tissue analytics acts as a clinical decision support tool to help staff make more
informed decisions (Tissue Analytics, 2019). Tissue Analytics, which was incorporated in 2014
and based in Baltimore, Maryland, is currently used in 25 states and by major healthcare
corporations, including Intermountain Healthcare, Bayfront Health, and Penn Medicine (Tissue
Analytics, 2019).
In addition to more accurate wound measurements, the tissue analytics platform would
improve documentation. Documentation of the skin assessment is as important as the assessment
itself; documentation also is very important in communicating PU status among staff (AHRQ,
2014). Documentation of POAs is very important in decreasing reimbursement penalties and
liability issues. Due to the benefits and potential positive impact on the organization, the
organization made the decision to implement a digital imaging platform using TA technology,
which is the focus of the DNP project.
Needs Assessment
There was a need for the organization to improve PU documentation and identification of
POAs and HAPUs to not only improve patient safety, but to meet the challenges of CMS
guidelines. These factors were positive motivators for stakeholders because it aligned with the
organization’s goals to provide high-quality patient care.
As for resources, the current environment includes interdisciplinary teams such as wound
care specialists, nurses, and physicians who all work together to prevent and treat HAPUs. The
previous process used by the team to decrease HAPUs RAS, standard guidelines, specialty beds,
barrier creams and wipes, flotation of heels, and support surfaces, paired RN assessment.
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However, despite the interventions, the experienced challenges in identifying POAs and
documenting PU information, including staging, location, and laterality.
Another challenge that the organization faced was poor inter-user reliability with the
Braden scale. According to Gould et al. (2018), the Braden scale is also not accurate in
predicting PU risk in certain populations such as patients in the Intensive Care Unit (ICU),
trauma patients, burn populations, and those with spinal cord injuries. Since the majority of the
patients with HAPUs in this organization were ICU patients, Braden scores were not sufficient in
assessing their risk.
As a solution, the organization decided to use a digital imaging platform using tissue
analytics along with the standard interventions. Since the TA technology had demonstrated
proven success in other organizations such as Intermountain Health and Penn Medicine, the
organization was encouraged. Also, implementing a digital imaging platform using TA to
improve the identification of POAs and improve the accuracy of documentation, aligned with the
organization’s mission to provide high-quality healthcare, advanced technology, and world-class
service to patients (GW, 2019).
In order to examine the needs of the organization in detail, A SWOT analysis was
performed. The SWOT helped to identify the strengths, weaknesses, opportunities, and threats to
the organization. See Figure 1 for the SWOT analysis for this project.
Problem statement
According to a review of the literature, HAPU rates remained high nationally despite use
of standard interventions (Gould et al., 2018). Several studies documented decreased patient
outcomes and quality and increased financial burden due to HAPUs (Han et al., 2018). Most of
the research showed that multimodal, multidisciplinary interventions are the most effective
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(Mallah et al., 2015). A needs assessment conducted at a hospital in the Level 1 trauma center
mid-Atlantic has documented the need for multimodal, multidisciplinary interventions to
improve the identification of POAs and improve the accuracy of PU documentation. To fill this
gap, the hospital implemented a digital imaging platform using tissue analytics (TA) to
supplement their current standard of care.
Practice Question
In all patients admitted to the hospital, does a digital imaging platform using TA along with the
standard of care compared to standard interventions alone affect identification and
documentation of POAs and HAPUs within two months of implementation?
The primary clinical question to achieve the study objectives/aim is:
1. Is digital imaging platform using TA effective in identifying the presence of POAs during
the admission skin assessment in order to prevent POAs from being incorrectly identified
as HAPUs?
The secondary clinical question is:
1. Does using a digital imaging platform using TA improve accuracy documentation of
staging and documentation of pressure ulcers in general?
Purpose Statement
The purpose of this project was to implement and evaluate a hospital-wide digital imaging
platform using TA with the current standard of care at a Level 1 Trauma Center Hospital in MidAtlantic in order to improve identification of pressure ulcers that are POA as well as to improve
the accuracy of documentation of PU staging and improve documentation of PUs and compare
two months pre- and two months post-intervention.
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Aim and Objectives
This DNP project aimed to properly identify POAs in admitted patients at a Level 1 trauma
center in the Mid-Atlantic after implementing a digital imaging platform using tissue analytics in
December 2019 along with the standard care protocol.
The objectives of this study were:
1. Improve identification of POAs during the admission process to prevent them from
being counted as HAPUs later during admission
2. Improve documentation of stages of POAs and HAPUs
3. Improve documentation of all PUs
Literature Review
The literature search for this study was completed from May 2019 to July 2019. PubMed,
CINAHL, and Google Scholar search databases were reviewed for articles that contained support
for the research questions. Medical Subject Headings (MESH) terms “hospital-acquired” and
“Pressure Ulcers” and “interventions” were combined with Boolean operators “AND” and “OR.”
Additional keywords “documentation,” “rates,” acute care,” “standard care,” “digital image
analysis,” “digital imaging,” “3D,” “wound” were searched to generate specific research articles
evaluating the effect of skin analysis intervention on pressure ulcer prevention. A manual search
for articles by references was also used to identify additional appropriate articles. The filters
applied were, humans, the publication year 2012-2019.
The inclusion criteria for this study were random design studies, pre-and post-test,
prospective cohort studies, quality improvement studies, adults with a diagnosis of pressure
ulcers, or at risk for pressure ulcers. The exclusion criteria included dissertations or thesis papers.
From the literature, the following themes emerged: risk factors for HAPUs, interventions for
HAPUs, mortality rates of patients with HAPUs, digital imaging as a supplement to assessment,
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and documentation challenges of PUs. See Appendix D for an Evidence Table with a synopsis of
the Literature.
Risk Factors for HAPUs
It is important to identify patients’ risk factors for PUs as soon as possible in order to
implement appropriate interventions in a timely manner (Gould et al., 2018). In a descriptive
study of 34,287 adult patients over the age of 65 admitted to the hospital from January 2011December 2015, Han et al. (2018) identified gender, age, admission method, perfusion status,
mobility, and Braden Scale Score as risk factors for HAPUs. However, unlike other studies, they
found that impaired consciousness had a significant impact as well; patients with impaired
consciousness had a 3.77 times rate of getting PUs versus alert patients (Han et al., 2018). In a
systemic review of 54 studies, including 34,449 patients, Coleman et al. (2013) also identified
age, gender, mobility status, and diagnoses such as hypertension and diabetes that caused
perfusion issues as risks to developing PUs.
Interventions for HAPUs
Standard interventions exist for preventing HAPUs (IHI, 2019). However, a multimodal
approach with multiple interventions is the most beneficial (Mallah et al., 2015). For instance,
Lam et al. (2018) found that a 7-step care-based process reduced the incidence of HAPUs in
9,755 trauma inpatients older than 15 years old. The 7-step plan included using specialized beds,
improved nutrition, repositioning protocol, staff education. Englebright et al. (2018) found that
HAPU rates decreased after implementing a comprehensive program in 149 hospitals from 20112013. The program combined evidence-based tools along with education with supplemental data
on PUs. As a result of the program, the rate of Stage 3 and 4 HAPUs decreased by 66.3%, while
the overall rates of ALL HAPUs decreased by 47.1%. In a study by Mallah et al. (2015), a
multidisciplinary intervention that included the use of the Braden scale, NPUAP-EPUAP 2009
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guidelines, nurse champions, RN education, electronic reporting, were implemented on a total of
486 inpatients at a tertiary medical center in Lebanon. The intervention significantly reduced the
prevalence of HAPU from 6.63% in 2012 to 2.47 in 2013 (Mallah et al., 2015.
Mortality rates of hospitalized patients with PUs
Along with causing discomfort and pain, HAPUs increases patient hospital LOS and
patient mortality (Manzano et al., 2014). In a prospective cohort study performed over two years,
Manzano et al. (2014) examined the mortality rate of ICU patients on Mechanical Ventilation
who developed a PU. Of the 563 patients studied, 110 developed a PU stage >2 while in the ICU
and their mortality rate was significantly higher than those who did not (60% versus 45.9%) In a
case-control study of 1000 patients with PUs in a tertiary hospital in Korea, Han et al., (2019)
found that hospital patients with PUs had higher mortality, LOS, costs, and hospital readmissions
than those who did not despite adhering to standard prevention guidelines.
Digital image analysis of PUs and wounds
In order to identify and treat HAPUs promptly, the skin assessment must be accurate and
concise. Digital imaging is increasingly being used for this purpose. Although no EBP research
was found on the specific tissue analytics software proposed in this project, studies demonstrate
the benefits and accuracy of using similar 3D imagery to measure and analyze wounds. In the
assessment of wounds in 87 patients, Wang et al. (2017) found that an Apple smartphone with a
Swift Wound app had higher-inter rater reliability and accuracy of measuring wounds and
tracking wound size and temperature than rulers. Although the standard ruler method yielded
reliable length and width measurements, these values were less accurate than the app. Also,
Wang et al. (2017) found that ruler-based measurements were less reliable in larger, irregular
wounds. Similarly, in a study of 45 wounds by Anghel et al. (2016), a 3-D wound measuring
(3DWM) device showed high reliability for measuring wound area in a range of wound sizes and
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types. Manual metric measurement overestimated the wound area in 41 of 45 wounds. Manual
median wound area values were significantly different from 3DWM device values. The findings
were consistent with other studies that showed that ruler measurements were 44% less accurate.
In a study of 81 photos of wounds from 25 patients, Budman et al. (2015) also found that using a
smartphone with 3D imaging and computer support increased the accuracy of measurement and
characterization of chronic wounds over the ruler measurement.
Documentation Challenges of PUs
Finally, accurate documentation of PU and treatment plan is essential in communicating
information amongst staff. Incorrectly documented information may delay treatment, prolong
healing, increase LOS, and result in increased cost to the organization. In a retrospective crosssectional review of 155 patient charts from 5 nursing homes, Hansen and Fossum (2016) found a
discrepancy between documentation of PUs on physical exam and progress notes. Some charts
indicated the presence of PUs on the exam but did not document any PU stages; other charts did
not document the presence of PUs on the exam but mentioned PU in the progress notes. Many
notes were also missing preventative measures used and treatment plan. Underreporting
preventative measures may be a liability (Hansen & Fossum, 2016). In a retrospective
comparative descriptive study of 196 ICU patients, Li (2016) also found poor documentation of
PU location, appearance, staging, and incomplete documentation of treatment and plan. These
documentation challenges further supported the benefits of technology such as digital imaging
platform using TA in increasing the accuracy of PU documentation.
Theoretical Framework
For this QI intervention, the IOWA Model (Figure 2) best addressed the clinical issue and
served as a guide for nurses and other health care providers to use research findings to improve
patient care (Titler et al., 2001). In addition to the IOWA model, the Implementation Strategies
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for Evidence-Based Practice Model was used to facilitate the implementation of this
intervention.
In the first step of the model, identifying a priority, the organization recognized the need
to improve the identification of POAs and improve the accuracy of PU documentation. After
performing a needs assessment and gap analysis, the hospital’s Wound Director, Director of
Nursing, and Director of Nursing Education identified the need for additional interventions aside
from the standard protocols and interventions. The hospital’s stakeholders were receptive to this
change in order to improve hospital quality and patient outcomes.
Steps 2 and 3 of the IOWA Model involve organizing a plan followed by forming a team,
respectively. Since the project site is extremely large, any intervention will have a huge impact.
Therefore, the immediate plan was to evaluate findings from other large institutions that had
used digital imaging platform using TA, document benefits including improved quality of care
and reduced hospital costs, then get buy-in from stakeholders. A team was formed that included
the Principal Investigator (PI), Wound and Ostomy and Continence Nurse (WOCN) Specialists,
clinicians, and the nurses in the hospital. Once the team was formed, brainstorming sessions
were held to identify the next steps (Doody & Doody, 2011).
For step 4, assembling literature and relevant research, clinical questions were developed
to direct the evidence search. Evidence related to the question was appraised. The researcher
searched Medline and CINAHL using resources from 2012 to the present. Keywords used
included “hospital-acquired,” “pressure ulcers,” and “interventions,” combined with Boolean
operators and additional keywords including “documentation,” and “rate.” A review of the
related studies emphasized the importance of recognizing risk factors for PUs, interventions to
prevent PUs, and the use of digital photography platforms to accurately capture PU
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measurements. A hospital-wide tissue analytics protocol, in conjunction with the current
standard of care protocol, was the proposed intervention to fill this gap.
In support of the next step, the evidence was critiqued and synthesized. Per review of the
literature, there were no EBP research articles on the specific technology proposed; however,
research existed on similar platforms. The organization was also encouraged to use the Platform
based on the success of many large hospital systems such as Intermountain Health and Penn
Medicine. According to the Tissue Analytics White paper report (Budman, 2019), the tissue
analytics software significantly improved both charting time and patient wound healing rates at
Intermountain’s Mckay-Dee Hospital in Utah (Budman, 2019). Mckay-Dee found that using the
TA software resulted in a 72% improvement in healing rate and a 12-day reduction in healing
time per wound on average (Budman, 2019).
Next, the evidence was reviewed and appraised. See Appendix D. Once the evidence was
sufficient, a plan was made to proceed with the pilot in November 2019. Based on pilot results,
work-flow adjustments were made to improve the process. The team was encouraged by the
initial results and proceeded with the hospital go-live in December 2019. A Practice policy and
protocol was formulated to incorporate the new intervention into practice.
The Implementation strategies for evidence-based practice (EBP) model was used to
facilitate the implementation stage. While the IOWA model provided a practical step-by-step
guide to move forward, the EBP model served as a guide to carefully evaluate and plan each
implementation step (Cullen, 2015). The Implementation Strategies for the EBP model was
meant to supplement the IOWA Model- not replace it (Cullen, 2015). The EBP Implementation
Model consists of four phases of implementation: (1) Create awareness and interest, (2) Build
knowledge and commitment, 3) Promote action and adoption, and 4) Pursue integration and
sustained use (Cullen, 2015).
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Using the Implementation Strategies for EBP, once the problem was identified, the team
created awareness and urgency through staff meetings, continuing education requirements on the
topic, and involvement of senior executives. Next, to gauge staffs' attitude towards PU
prevention, a staff attitude survey was conducted pre-intervention. Staff with the highest scores
(and thus most positive attitudes toward PU prevention) were selected as skin “champs” on the
unit. In accordance with the next step of the EBP- promoting action and adoption- staff were
trained and mentored by skin champs and change agents. Also, the EMR was integrated with the
TA software. The actions and adoption change took several weeks. The positive feedback from
the pilot was encouraging, and the hospital-wide implementation occurred in December 2019.
Finally, the last stage was integrating the new practice into the workflow and sustaining
its use (Cullen & Adams, 2012). The organization sustained the new practice by regularly
monitoring quality measures and reporting successes to senior leaders with reports on the impact
of the technology on patient quality of care.
Methodology
This quality improvement study evaluated patients who received the digital imaging
platform using TA in conjunction with the current standard of care protocol versus those who
received the current standard of care alone without digital imaging. The purpose of the project
was to compare the identification of POAs, improve the accuracy of documentation of PU
staging, and improve the documentation of PUs two months pre-intervention and two postintervention.
Human Subject Determination was obtained. Data were extracted from the hospital’s
NDNQI measures as well as from chart audits. Measurements included POAs, HAPUs, and PU
stages. Other data collected were demographic information, Braden scale, and a Pre-intervention
staff attitude survey.
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The presence of POA PUs was noted from the initial skin assessment. POAs are
documented in the EMR within 72 hours of admission by the admitting/primary service, and
information from the chart audit was used in data collection. For HAPUs, the date of onset was
defined as the date that the HAPU was identified and recorded in the hospital’s documentation.
Demographic information was collected from chart audits. Tools used included the Braden Scale
and AHRQ toolkit.
The NDNQI values and demographic information were entered into an Excel spreadsheet
and analyzed in Excel. Then the Statistical Package for the Social Sciences (SPSS version 26)
was used to analyze the data (IBM Corp, Armonk, NY). Descriptive statistics were used to
describe the sample; for categorical data, the results were reported using frequency and
percentages. The data was password protected and secured in a locked file cabinet in the author’s
office. Only the PI and the wound nurse had access to this data.
A logic model was used as the program planning tool for this project (McCawley, 2001).
The logic model aligned with the four dissemination phases of the IOWA model and included
the short-term, mid-term, and long-term goals of the implementation. See Figure 3 for a detailed
Logic Model for this project.
Setting
The setting for the project was a level 1 Trauma Center in the Mid-Atlantic with 420
beds. This is an academic medical center in which patients receive specialized, complex care due
to a range of specialty services, including midwifery services, rehabilitation services,
cardiovascular center, and neurosciences institute, wound healing, and limb preservation Center.
Additionally, there are several units dedicated to acute services such as the Intensive Care Unit
(ICU), pressure ulcer management, orthopedics, acute stroke, and medical-surgical services. In
2018, there were 20,777 inpatient admissions.

Implementing a Digital Imaging Protocol
22

Sample
The sample was a convenience sample of inpatients from multiple units since the
intervention was hospital wide. The target population was patients under the care of the wound
team. Inclusion criteria were all admitted patients. Exclusion criteria were hospice patients,
patients with a length of stay (LOS) less than 24 hours (this included observation less than 24
hours, same-day surgery, emergency department, and other ambulatory care patients), pregnant
patients, and pediatric patients.
Study Interventions
Patients admitted the hospital signed a consent for treatment, which included terms for
the digital imaging technology (see Appendix F for consent form). Then patients received an
admission assessment (ideally within 4 hours of admission), which included a risk assessment
and skin assessment. If the admitting nurse detected ANY skin abnormalities, the digital imaging
platform using TA was used during the assessment. This process not only improved the
identification of POAs but improved documentation of any skin abnormalities that may
incorrectly be identified as PUs later- including IV filtration wounds, venous ulcers, and/or skin
tears. The digital imaging platform using TA intervention was implemented along with the
standard protocol.
Implementation of the intervention was headed by the hospital’s wound team from the
Wound Healing and Preservation Center. This team includes 2 Wound Ostomy and Continence
Nurse (WOCNs), 3 Nurse Practitioners (NPs). The team generally sees an average of 30 patients
at a time. They consult on patients with all types of wounds - including both PU and non-PU.
The DNP student worked closely with the Wound Center Director and the Director of
Professional Development and Education throughout this project.
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Staff was administered an AHRQ Staff Attitude Survey to determine their attitude
towards PU prevention and to identify “skin champs” for the units. (See Appendix E). Staff was
trained and given a step-by-step guide on how to integrate the technology into the workflow.
All nurses were equipped with a HIPAA compliant smartphone that contained the tissue
analytics app. Once a skin abnormality or PU was identified during the assessment, the nurse
selected the patient’s name from a list of admitted patients and captured the image. The nurse
selected the part of the body where the wound was found using the human body avatar depicted
on the screen. The nurse entered other characteristics of the wound, such as location, laterality,
and documented whether it was POA. Next, the operator selected another option that sent the
analysis wirelessly to the Cerner EMR. Once downloaded to Cerner, none of the images were
retained on the physical phone. See Figure 4 for Step-by-Step instructions on how to use the
digital imaging platform using TA.
The tissue analytics staff was available during the implementation process to assist the
organization with trouble-shooting equipment and software issues. The hospital staff received
additional support from in-service meetings, professional education and development
department, the wound team, skin champions, and super users on all floors.
Timeline
The project started in September 2019 and was implemented over a 22-week period,
ending in February 2020. Pre-intervention data was collected from September and October 2019.
The pilot month of November was excluded in data analysis. Hospital-wide implementation
began on December 9. Post-intervention data were collected in January and February 2020. See
below for further details. Also, refer to Figure 8 Gantt Chart for timeline.
IRB approval was obtained on September 4, 2019. Weeks 1-3-Policy and guidelines were
drafted to incorporate the new technology into the existing policy. Announcements were made
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about the upcoming technology and the go-live date. Weeks 4-6 -staff was trained on the new
equipment and workflow.
Weeks 7-8-staff training continued; also, the wound team prepared for the pilot in
November. Equipment was received and leaders continued developing the policy. During weeks
8-12, there was a pilot intervention on patients under the care of the Wound team to identify,
modify, and/or adjust areas of improvement before the hospital-wide implementation in
December. This pilot on a small segment of patients was done to minimize disruptions to this
high-volume hospital’s work-flow. The PI completed data collection from the pre-intervention
months of September 2019 and October 2019. Lastly, weeks 13-22 -The PI collected and
analyzed data from the post-intervention months of January 2020 and February of 2020.
Resources needed
Resources needed included staff time for meetings and initiatives, leadership time to
monitor and support team efforts, training, and education time (AHRQ, 2019). Staff meetings
and training sessions were incorporated into the regular work schedule and staff were paid their
regular rate. Technology for the digital imaging platform using TA, software, and training
material were included in the company’s budget, and was funded by the hospital.
Data Collection
A non-human subject research determination from GW’s Institutional review board (IRB)
was obtained. Data, including HAPU rates and POA occurrences, were collected from chart
audits and NDNQI reports two months pre-intervention and two months post-intervention.
Braden scores were collected and the frequency, percentage, and mean scores were calculated
pre-intervention and post-intervention. A staff attitude survey was completed pre-intervention
(See Tables 3).
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The Pilot month of November was not included in the data analysis since the patients in
the pilot were already admitted; their POAs were already known. The hospital go-live month of
December was also not included in the data analysis since the staff was adjusting to the
technology. Therefore, pre-intervention data was collected from September and October 2019;
post-intervention data were collected from January and February 2020. A data collection sheet
was used to collect pertinent information (See Appendix I); this sheet, along with all data, was
kept in a secure binder for the PI to access for analysis. In order to ensure patient privacy, all
patient identifiers were removed. Additionally, patient charts were number coded.
Evaluation plan
Evaluation measures included (1) Measure of HAPUs, (2) Measures of POAs (3)
Frequency and percentage of Braden scores. Demographics of participants of the staff attitude
survey were documented (see Table 2). Scores of each item in the survey were calculated (see
Table 3). Chart audits were completed to ensure that a comprehensive skin assessment AND a
standardized risk assessment such as the Braden scale were completed within 24 hours of
admission.
Tools used included the Braden scale (BS) and AHRQ toolkit. The BS showed good
inter-rater reliability ranging from 83% to 99% in multiple clinical settings (Jackson, 2011). The
sensitivity and specificity of the BS are high (0.83-1.00 and 0.64-0.90, respectively) when the
cut-off score of 16 is used (Jackson, 2011). For BS scores ranging from 12-20, the sensitivity of
the scale ranges from 29% to 93%, while the specificity ranged from 67% to 97% (Jackson,
2011).
The hospital wound team used the AHRQ toolkit as a framework to implement the new
PU prevention strategy and sustain efforts. The toolkit draws on the literature of best practices in
PU prevention and includes both validated and newly developed tools (AHRQ, 2014). The
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toolkit was tested in six participating medical centers (AHRQ, 2014). A survey from the AHRQ
toolkit was used in this study to assess staff attitude and to identify any knowledge gaps. The
Staff Attitude Scale was used to provide useful feedback on clinical staffs’ beliefs regarding
pressure ulcer prevention (AHRQ, 2014). The AHRQ staff attitude survey is an 11-item
questionnaire graded on a Likert 5-point scale, with total scores ranging from 11-55. Positive
perceptions are presented by a score > 40 (Wong et al., 2018). The staff knowledge and attitude
surveys were collected through an electronic survey through Monkey Survey. See Table 3 for the
results.
Data Analysis and, Maintenance and Security
The incidence of HAPUs and POA rates was measured to evaluate the effectiveness of
this QI project. The author worked closely with the wound care Director to create a report that
included patients with HAPUs and POAs. Incidence of POAs and HAPUs were collected from
NDNQI measures and chart audits.
Data was imported into and analyzed using SPSS version 26 for Windows (IBM Corp.,
Armonk, NY). Frequency tables and descriptive statistics were used to summarize the
demographics of the participants (i.e., gender, race, age, and Braden score, pre-and-post
intervention), documentation of the stages of POA and HAPUs (pre-and-post intervention),
Braden score (pre-and-post intervention), and AHRQ staff attitudes survey (pre-intervention
only).
For Aim 1, improve identification of POAs upon admission assessment, we measured the
factors: POA identification rate, frequency, and percentage of all POAs, and HAPU Incidence
rate. The frequency of POAs was calculated per 1000 admissions for September and October of
2019 (pre-intervention) and January and February of 2020 (post-intervention) and compared
using incidence rate ratio and 95% confidence intervals (CI) (Polit, 2010; Giles et al., 2006,
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Rosner, 2011). The HAPU incidence rates were also calculated to compare pre- and postintervention. The assumption was that as more POAs were correctly identified, and less HAPUs
were incorrectly identified as POAs, the number of HAPUs would decrease.
To examine aim 2, promote accurate documentation of the stages of POA and HAPUs, a
chi-square test of independence was used to determine if there was a statistically significant
difference in the documentation of the stages of POA and HAPUs between pre-intervention and
post-intervention. Since the sample size was small, the p-value of the chi-square test was
obtained via the Monte Carlo method (Mehta & Patel, 2011). For all tests, a p-value of less than
0.05 was considered significant. Data analyzed included stages of the PUs: Stage 1, II, III, IV,
unstageable, or deep tissue injury (DTI) for both POA and HAPUs. Additionally, medical
device-related (MDR) PU stages were added for HAPUs. And since POAs included ALL skin
abnormalities, including non-pressure ulcer wounds, a unique category of "no stage" was added
for POAs.
To examine aim 3, improve documentation of PUs, we wanted to compare the actual PU
prevalence pre- and post-intervention to determine if there was a difference in the documented
PU rates after using the technology. The assumption is that if PUs (either POAs or HAPUs) were
being overlooked or not properly identified during assessments, the organization might see an
increase in the overall PU prevalence numbers post-intervention due to the concise monitoring
and tracking of the digital imaging platform using TA.
For this aim, the PU prevalence rate was calculated pre- and post-intervention using the
AHRQ PU prevalence formula below:
Number of patients of patients with HAPUs
Total number of patients admitted

X 100
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The current PU prevalence benchmark rate is 3.3% (Hill-Rom, 2019). Since this study
occurred over a short time frame, the national annual rate (3.3%) was divided by 12 months in
order to calculate a monthly rate (0.275%). The monthly prevalence rates calculated in this
study for each pre- and post-intervention month were compared to 0.275% in order to assess the
organization’s status in comparison to the national benchmark.
The data was password protected and secured in a locked file cabinet in the author’s
office. Only the PI and the wound nurse had access to this data.
Ethical Considerations
This intervention was non-invasive and was not expected to cause any harm to the
patients. An IRB approval was obtained before the study started. The study proposal was
approved for non-Human Subject Determination. Consent was obtained by all patients prior to
the study through the hospital’s consent for treatment. See Appendix F. The consent contains a
section that states, “By my signature below, I consent to laboratory studies (HIV, HBV, HCV) in
the event a health care worker is exposed to my blood or body fluids. I consent to the appropriate
disposal of any tissue or part removed from my body and to the taking of photographs during
the procedure/operation/treatment for research, teaching, or scientific purposes as long as
my identity is not disclosed” (GW Hospital, 2019). Video photography was covered under this
section. Patients were neither paid nor given any extra incentives for this intervention.
The PI created a codebook that contained the study numbers for any patient identifiers
used. The codebook will be deleted within 30 days after the DNP project is submitted. The
desktop computer used for this study was password protected. The desktop computer was kept in
a locked office, and all data collected for this study was saved on a flash drive and kept in a
secure locked cabinet to ensure privacy and protection of PHI.

Implementing a Digital Imaging Protocol
29

Results
Characteristics of the Sample
There were 55 participants (N = 23 for pre-intervention and N = 32 for post-intervention)
included in this study (which resulted in 72 incidences of HAPUs). Table 1 shows the
characteristics of the sample. Of the pre-intervention participants, the majority were male
(82.6%); of the post-intervention participants, half of them were male (50.0%). For both the preand post-intervention period, over half of the participants were Black (52.2% for pre-intervention
and 59.4% for post-intervention). The average age for the participants was 66.21 years (SD =
11.07) and 61.88 years (SD = 17.20) for pre-intervention and post-intervention, respectively. The
average Braden score for the participants was 14.52 (SD = 3.65) and 14.56 (SD = 2.55) for preintervention and post-intervention, respectively. See Appendix G for the descriptive statistics for
the demographics of the study. See Figure 5 for Braden Score distribution.
Figure 5: Braden Score distributions Pre and Post Intervention
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AIM 1: Improve Identification of POAs upon Admission Assessment
To analyze if there were any difference in the number of POAs identified preintervention and post-intervention, the POAs per 1000 patient admissions were computed for two
periods to get the identification rate: (1) September and October of 2019 (pre-intervention) and
(2) January and February of 2020 (post-intervention). For pre-intervention, there were 21 POAs

Implementing a Digital Imaging Protocol
30

and 4112 patient admissions; for post-intervention, there were nine POAs and 3996 patient
admissions. Thus, the POA identification rate for pre-intervention was 5.11 POAs per 1000
patient admissions (95% CI = [3.33, 7.84]), and the POA identification rate for post-intervention
was 2.25 POAs per 1000 patient admissions (95% CI = [1.17, 4.33]) (Table 2). The incidence
rate ratio of the POA identification rate between pre and post-intervention was 2.27 χ2 (1) =
4.223, p = 0.040; 95% CI = [1.04, 4.95]), indicating that the POA identification rate for preintervention was statistically significantly higher than the POA identification rate for the postintervention. See Table 1.
Table 1: POAs per 1000 Patient Admissions
POAs Patient admissions
POA identification rate [95% CI]
Pre

21

4112

5.11 [3.33, 7.84] POAs per 1000 patient admissions

Post

9

3996

2.25 [1.17, 4.33] POAs per 1000 patient admissions

Note. POA identification rate = (Number of POAs/Number of patient admissions) *1000.
HAPU Incidence Rate
The purpose of Aim 1 was to improve the identification of POAs and prevent them from
later being counted as HAPUs. The assumption was that with the digital imaging platform using
TA, the number of POAs post-intervention would increase (due to improved identification), and
the number of HAPUs would decrease (since less POAs would be counted as HAPUs). In order
to analyze this assumption, the HAPU incidence rates were calculated and compared pre- and
post-intervention using the AHRQ formula below:
Number of patients with HAPUs
Total number of patients admitted

X 100
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Figure 6: HAPU Incidence Rates
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The HAPU rates increased exponentially in February 2020. Factors contributing to this
increase is discussed in the “Discussion” section of this paper.
Aim 2: Improve Documentation of Stages of POA and HAPUs
The total number of HAPUs observed in this study was 72, with 37.5% (N = 27) being in
pre-intervention and 62.5% (N = 45) being in post-intervention. Of the 27 incidences of HAPUs
pre-intervention, the top three stages documented were deep tissue injuries (33.3%), stage 2
ulcers (29.6%), and unstageable (25.9%). Of the 45 incidences of HAPUs post-intervention, the
top three stages documented were deep tissue injuries (57.8%), stage 2 ulcers (24.4%), and
unstageable (6.7%). A chi-square test of independence was performed to determine if there was a
statistically significant difference in the documentation of the stages of HAPUs between preintervention and post-intervention. As the sample size was small, the p-value of the chi-square
test was obtained via the Monte Carlo method (Mehta & Patel, 2011). The results of the chisquare test of independence indicated that there was no statistically significant difference in the
documentation of the stages of HAPUs between pre-intervention and post-intervention (χ2 (5) =
9.823, p = 0.059).
The total number of POAs observed in this study was 30, with 70.0% (N = 21) being in
pre-intervention and 30.0% (N = 9) being in post-intervention. Of the 21 incidences of POAs
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pre-intervention, the top three stages documented were unstageable (28.6%), no stage (nonpressure ulcers) (28.6%), and deep tissue injuries (23.8%). Of the 9 incidences of POAs postintervention, 66.7% were stage 3 ulcers and 33.3% were no stage (non-pressure ulcers). A chisquare test of independence indicated that there was a statistically significant difference in the
documentation of the stages of POAs between pre-intervention and post-intervention (χ2 (6) =
16.395, p = 0.003).
Aim 3: Improve Documentation of all PUs
In order to determine if the digital imaging platform using TA technology impacted the
documentation of PUs, the PU prevalence rate was calculated pre- and post-intervention. This
rate was calculated using the AHRQ formula below:
Total number of patients with PUs (both POAs and HAPUs) x 100
Total number of admitted patients
The digital imaging platform using TA could affect the PU prevalence in two main ways:
1) With improved identification of both POAs and HAPUs, the post-intervention PU prevalence
rate would be higher; 2) Or, alternatively, the post-intervention PU prevalence rate would be
lower due to less non-PU wounds were being categorized as PUs. Either way, a change would be
expected. The PU prevalence rates from the organization are found in Figure 7.
Figure 7: Pressure Ulcer Prevalence Rates
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The acute care national benchmark for PU Prevalence rate is 3.3% annually (Hillrom,
2019). However, due to the short period of the study, we are interested in the monthly prevalence
rate. Therefore, if we divide the national benchmark, 3.3%, by 12, the national monthly PU
prevalence rate would about 0.275%. The monthly prevalence rates for this organization were
higher than 0.275% and peaked at 1.17% in February 2020.
AHRQ Staff Attitudes’ Survey towards Pressure Ulcer Prevention
Two-hundred and seventy-eight (278) clinical staff members participated in the AHRQ
staff attitude survey. Table 2 shows the demographics of the staff. Most of the respondents were
female (89.6%). Respondents indicated that they work in medical/surgical (39.5%), clinical care
(21.5%), ED (11.1%), OR/PACU (13.3%), and women’s health (14.6%). See Table 2 for the
demographics of participants of this survey.
Table 3 summarizes the responses from the AHRQ staff attitudes survey. The top three
items that the respondents disagreed on were:
(1)

I do not need to concern myself with pressure ulcer prevention in my practice
(Item 4, M = 4.60)

(2)

Pressure ulcer treatment is a greater priority than pressure ulcer prevention (Item
5, M = 4.24)

(3)

In comparison with other areas of care, pressure ulcer prevention is a low priority
for me (Item 10, M = 3.88)

The top three items that respondents agreed on were:
(1)

Pressure ulcer risk assessment should be regularly carried out on all patients
during their stay in hospital (Item 11, M = 1.50)

(2)

Continuous assessment of patients will give an accurate account of their pressure
ulcer risk (Item 6, M = 1.52)
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(3) All patients are at potential risk of developing pressure ulcers (Item 1, M = 1.59)
Discussion
Aim 1: The POA identification rate was significantly higher in the pre-intervention
period. This finding contradicts our assumption that there would be improved identification of
POAs (and, therefore, increased numbers) post-intervention due to the digital imaging platform
using TA. Possible explanations include: 1) The study contained several patients with more than
one POA in the pre-intervention period. For instance, one 90-year-old patient in the preintervention month of October had NINE POAs of varying stages; and 2) the POAs documented
only came from a small convenience sample of patients. There were surely more patients outside
of this sample who had POAs. Therefore, the post-intervention numbers for the hospital are
likely much higher than those found in this study.
Also, contrary to our assumption, the HAPU incidence rates were higher postintervention. This finding was mainly due to the high number of patients with device-related
HAPUs in the month of February 2020. There were 14 HAPUs in February that were caused by
devices such as condom catheters, endotracheal tube holders, pulse oximeters, and knee
immobilizers. Most of the patients with devices were in the ICU and had limited mobility and
decreased levels of consciousness. These patients required the devices for treatment. This result
demonstrates that factors such as patient acuity plays a huge role in PU development. Standard
guidelines and interventions such as digital imaging platform using TA are only part of the
puzzle. These results also present an opportunity for improved device-related care, but this is
outside the scope of this project.
Aim 2: The results demonstrated no significant statistical change in the documentation of
HAPU stages pre-intervention and post-intervention. However, there was a significant
documentation difference in POA stages pre-intervention and post-intervention. The POAs
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included ALL skin abnormalities, including non-pressure ulcer wounds. There were a large
number of non-pressure ulcer wounds and mucosal injuries in this study. These included venous
stasis ulcers, IV infiltration wounds, and skin tears. These non-PU wounds and mucosal injuries
cannot be assigned a stage. The decision to include them in the analysis was for tracking
purposes since non-PU abnormalities may have occasionally been documented as PUs before the
implementation of the digital imaging platform using TA. LeBlanc, Alam, and Langemo (2016)
reported that skin tears often mimic DTIs and Stage 2 PUs; consequently, misdiagnoses may
occur. Misdiagnoses can result in inappropriate prevention and treatment strategies as well as
risk for re-injuries (LeBlanc, Alam, & Langemo, 2016).
Aim 3: The national annual benchmark for PU prevalence is 3.3% (Hill-Rom, 2019). In
order to calculate a monthly estimate from the national benchmark, 3.3% was divided by 12,
resulting in 0.275%. The PU prevalence rate for each month in this study was greater than
0.275%. In fact, the rate increased to 1.17% in February 2020. Again, as previously discussed,
this was due to a large number of device-related PUs in February.
Digital imaging platform using TA more accurately tracked PU progression than the
Braden Scale in this study population, which consisted mostly of ICU patients. Most of the
Braden scores in the post-intervention sample were in the mild-risk category (N=13), while the
actual PU prevalence in the post-intervention period was high. This finding is consistent with a
study by Griswold et al. (2017) that the Braden scale is not useful in predicting the occurrence of
ulcers in the trauma and burns populations. Other factors not included in the Braden Scale should
be considered in this population, such as age, level of consciousness, oxygenation, and perfusion
(Griswold et al., 2017).
And finally, the staff attitude survey demonstrated the need for staff training, in-services,
or incentives to increase positive attitude towards PU prevention measures. The total mean score
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for the survey was 33.36. Scores >40 represent positive perceptions (Wong et al., 2018). Scores
lower than 40 indicate negative attitudes towards HAPU prevention and one of the
organization’s early goals should be to address these misperceptions (Wong et al., 2018; AHRQ,
2014).
Study Limitations
The limitations of this study included the small sample size. Out of the 8,108 patients
admitted during this study period, there were 55 patients with HAPUs. Also, because the study
participants included only those with HAPUs, the POA numbers were strictly from this
population. This means that there were many more POAs detected than accounted for in this
study. Another limitation was the sample was a convenience sample rather than a random one.
Random sampling may yield the least bias.
The statistical methods used (Chi-Square and Monte Carlo methods) are usually better
suited for larger-sized, random samples. However, per McHugh (2013), although inferential
statistics assume random sampling, it is not uncommon for inferential statistics to be used with
convenience samples. Also, the Monte Carlo method was used to find the p-value in this study.
The Monte Carlo methods offer a way to draw statistical inference when traditional statistical
assumptions are violated (Waller et al., 2003). However, according to some sources, the
solutions of the Monte Carlo are not exact; outputs are estimates (Applied R&M, 2012). This
study needs to be replicated in a large size, random sample to be further validated.
Impact on Practice and Recommendations
We recommend the continued use of digital imaging platform using TA technology to
provide more precise measurements of PUs and thus improved accuracy of staging. This
technology can also track PU progression and treatment, which improves communication
between staff, prevents treatments from being duplicated or underused. These factors can
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promote faster healing of the PU. Quicker healing of PUs saves the organization money by
preventing the ulcers from progressing to a higher stage and by decreasing the hospital length of
stay (LOS). Higher staged ulcers cost more money to heal than lower staged ones. For example,
treatment for stage III and IV ulcers range from $5000 to $151,700 per ulcer (Meddings et al.,
2015), while stage I and II PUs cost a few hundred to a couple of thousands. In terms of LOS,
according to Lyder et al., (2012), PUs can increase the LOS from 4.8 for those without PUs to
11.2 days for those with HAPUs. Quicker healing could potentially decrease the LOS by several
days, saving the hospital thousands of dollars per person on average
We recommend the use of this technology for accurate identification of skin
abnormalities to prevent non-Pressure Ulcer wounds from being inaccurately categorized as PUs.
For instance, IV infiltration wounds, venous ulcer wounds, and other skin issues may have
incorrectly been identified as PUs before the intervention. The digital imaging platform using
TA ensured that staff documented the etiology of wounds as well as progression. Having a visual
image to refer to also confirmed the status.
We recommend using the digital imaging platform using TA in place of the Braden
scale in the ICU population. For this population, digital imaging using TA, along with standard
protocol, proved to be a more accurate indicator of PU risk than Braden scores. Eliminating the
Braden scale may save staff time that can be utilized for other tasks.
We recommend initiating staff activities or incentives to help improve staff attitudes
towards PU prevention. Improving staff’s attitude may encourage them to perform the
interventions eagerly.
Sustainability
In order to sustain the new intervention, support will take the form of training new
employees, offering refresher training courses for current employees; promptly filling staff
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vacancies; keeping in contact with facilities management for supplies and equipment and using
the assistance of information technology staff support to assist with regularly reporting
monitoring data (AHRQ, 2014).
Conclusion
Despite the limitations, this innovative technology has promise for the future. It helps to
improve PU documentation by providing more detailed, accurate descriptions of PUs. It also
provides an easy way to track the progression and treatment of PUs with its charts and alert
indicators. This intervention also helped organize PU data more efficiently in the EMR and
saved staff time in documentation since the information flowed wirelessly to the EMR. We
recommend that the intervention be replicated with a larger-sized, random sample and over a
longer time frame to be further validated.
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Figure 2: IOWA MODEL

* Titler, M., et al (2001). The IOWA model of evidence-based practice to promote quality care. Critical
Care Nursing clinics of north America. 13(4); 497-509.
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Figure 3: Logic Model for Skin Analytics Implementation
Program: Skin Analytics software integrated with standard protocol
Situation: Need for more accurate skin assessment during admission, need to reduce HAPU rates, need to distinguish HAPU vs POA pressure ulcers
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Figure 4: Step by Step Instructions to use Digital Imaging Platform using Tissue Analytics
User opens Cerner and add the patient to the TA app by clicking on the Tissue analytics Mpage
view tab in the patient’s chart. Then the patient will appear in the TA app.
i.

Using the TA app, take a wound image

ii.

Select the appropriate type of wound:
1. Pressure injury (ulcer) general
2. Pressure injury (ulcer) device-related
3. Non-pressure injury

iii.

Enter a wound number to assist in tracking. This number is not part of the patient’s
record.

Iv. Document in the dynamic group fields, as appropriate, but must include the following
fields:
1. Incision, wound laterality
2. Incision, wound location
3. Incision, wound location description
4. Present on Admission
V. These fields are the same as in iView
Tap continue to send the wound photo and documentation to the patient’s
chart
vi. Navigate to Tissue Analytics mpage view. Navigate to new wound documentation
>click on button for “Sign & Lock” . Image will now appear in multimedia manager and
discrete data will appear in iView>Incision, wound dynamic group
Discrete data will pull into iView as new dynamic group (if user added a new
wound) or in existing dynamic group (if user added a new evaluation to an
existing wound). If issues with data being downloaded, refresh and/or log in
and out of Cerner
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Figure 8: GANTT CHART -Project Timeline
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Tables
Table 2: Demographics of the Clinical Staff who took AHRQ Staff Attitude’s Survey
N (%)
Gender

Work unit

Female

249 (89.6)

Male

29 (10.4)

Missing response

0

Medical/Surgical

92 (39.5)

Critical care

50 (21.5)

ED

26 (11.1)

OR/PACU

31 (13.3)

Women’s Health

34 (14.6)

Missing response

45

Implementing a Digital Imaging Protocol
53

Table 3: Summary of AHRQ Staff Attitudes Survey Responses
Item
1. All patients are at potential risk of developing
pressure ulcers
2. Pressure ulcer prevention is time consuming for
me to carry out
3. In my opinion, patients tend not to get as many
pressure ulcers nowadays
4. I do not need to concern myself with pressure
ulcer prevention in my practice
5. Pressure ulcer treatment is a greater priority
than pressure ulcer prevention
6. Continuous assessment of patients will give an
accurate account of their pressure ulcer risk
7. Most pressure ulcers can be avoided
8. I am less interested in pressure ulcer prevention
than other aspects of care
9. My clinical judgment is better than any
pressure ulcer risk assessment tool available to me
10. In comparison with other areas of care,
pressure ulcer prevention is a low priority for me
11. Pressure ulcer risk assessment should be
regularly carried out on all patients during their
stay in hospital

% of survey response
1
2
3
57.82 32.36 4.00

4
4.73

5
1.09

N
M
275 1.59

5.49

16.48 21.25 36.63 20.15 273 3.49

2.19

10.58 24.45 45.99 16.79 274 3.65

1.09

1.45

2.54

26.09 68.84 276 4.60

2.54

3.26

.42

37.32 47.46 276 4.24

52.19 45.62 0.73

0.73

0.73

274 1.52

36.50 51.09 9.12 2.55 0.73 274 1.80
2.19 11.68 21.90 40.88 23.36 274 3.72
4.38

14.96 31.39 37.96 11.31 274 3.37

2.55

7.66

15.69 47.08 27.01 274 3.88

57.97 38.04 1.81

0.72

1.45

276 1.50
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Appendices
Appendix A: Elements of a Comprehensive Skin Assessment
Skin Temperature


Most clinicians use the back rather than the palm of their hand to assess the temperature of a patient's
skin.



Remember that increased skin temperature can be a sign of fever or impending skin problems such as a
Stage I pressure ulcer or a diabetic foot about to ulcerate.



Touch the skin to evaluate if it is warm or cool.



Compare symmetrical body parts for differences in skin temperature.
Skin Color



Ensure that there is adequate light.



Use an additional light source such as a penlight to illuminate hard to see skin areas such as the heels or
sacrum.



Know the person's normal skin tone so that you can evaluate changes.



Look for differences in color between comparable body parts, such as left and right leg.



Depress any discolored areas to see if they are blanchable or nonblanchable.



Look for redness or darker skin tone, which indicate infection or increased pressure.



Look for paleness, flushing, or cyanosis.



Remember that changes in coloration may be particularly difficult to see in darkly pigmented skin.
Skin Moisture



Touch the skin to see if the skin is wet or dry, or has the right balance of moisture



Remember that dry skin, or xerosis, may also appear scaly or lighter in color.



Check if the skin is oily



Note that macerated skin from too much moisture may also appear lighter or feel soft or boggy.



Also look for water droplets on the skin. Is the skin clammy?



Determine whether these changes localized or generalized.
Skin Turgor



To assess skin turgor, take your fingers and "pinch" the skin near the clavicle or the forearm so that the
skin lifts up from the underlying structure. Then let the skin go.



If the skin quickly returns to place, this is a normal skin turgor finding.
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If the skin does not return to place, but stays up, this is called "tenting," and is an abnormal skin turgor
finding.



Poor skin turgor is sometimes found in persons who are older, dehydrated, or edematous, or have
connective tissue disease.
Skin Integrity



Look to see if the skin is intact without any cracks or openings.



Determine whether the skin is thick or thin.



Identify signs of PUritis, such as excoriations from scratching.



Determine whether any lesions are raised or flat.



Identify whether the skin is bruised.



Note any disruptions in the skin.



If a skin disruption is found, the type of skin injury will need to be identified. Since there are many
different etiologies of skin wounds and ulcers, differential diagnosis of the skin problem will need to be
determined. For example is it a skin tear, a pressure ulcer, or moisture-associated skin damage or injury?



Use Digital Imaging Platform using Tissue Analytics (NEW)
*AHRQ (2019). AHRQ Toolkit. Retrieved from
https://www.ahrq.gov/professionals/systems/hospital/pressureulcertoolkit/putool7a.html#Tool2H
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Appendix B: Braden Scale
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Appendix C: Updated Pressure Injury* Stages
*Formerly Pressure Ulcers

*Retrieved online from Hill-ROM clinical resource center

https://library.hill-rom.com/Global/Supporting-Evidence/US%20%20EN/Pressure%20Ulcer%20Management/CTG090rcr11-Wound%20Staging%20BradenCard-LR.pdf
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Appendix D: Evidence Table
Authors

Anghel, E.,
Kumar, A.,
Bigham, T.,
Maselli, K.,
Steinberg, J.,
Evans, K., Kim,
P., & Attinger,
C.
(2019).
Budman J,
Keenahan K,
Acharya S,
Brat G. (2015).

Coleman, S.,
Gorecki, C.,
Nelson, E.,
Closs, S.,
Defloor, T.,
Halfens,
Ruud…&Nixon,
J. (2013)
Englebright,
M., Westcott,
B., Mcmanus,
B., Kleja, B.,
Helm, B.,

Journal
Name/WGU
Library
Wounds

Year of
Research Design
Publication

Sample
Size

2016

Quasiexperimental

45

iProc

2015

Quasiexperimental

International 2013
Journal of
Nursing
Studies

Journal of
patient
safety

2018

Outcome
Variable
Measured
Accuracy of
wound
measurement
of smartphone
3DWM

Leve
(IIII)
II

Quality Results/Author’s
(A, B,
Conclusions
C)
B
3Dwound measuring
device more accurate than
manual ruler
measurement in assessing
wound area

81

Accuracy of
wound
measurement
of a
smartphone 3D
system

II

B

3D measuring device more
accurate in measuring
than ruler measurement

Systemic review

34,449

Risk Factors of
HAPUs

III

B

QuasiExperimental

149
Rates of
facilities reduction of
Pressure Ulcers
(PUs)

II

B

Identified that there is no
single risk factor for PU
development in adults but
a complex interplay of
factors, with the top 3
being mobility/activity,
perfusion and
skin/pressure ulcer status
The implemented
Reducing HA PUs program
resulted in reduction of
HAPUs across the system
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Korwek, B., &
Perlin, B.
(2018).

Han, S., Kim,
Y., Hwang, J.,
Lee, J., & Song,
M. (2018)

Journal of
Clinical
Nursing

2017

Descriptive
Study

34,287

Predictors of
PUs in older
patients

III

B

Hansen, R. &
Fossum, M.
(2016)

Nursing
Open

2016

Cross-sectional
descriptive
design

155

Documentation III
of PUs stages,
prevention
methods

B

Han, Y., Jin,Y.,
Taixian, J., Lee,
S., Lee, J.
(2019)

Journal
Wound
Ostomy
Continence
nurs
American
College of
Surgeons

2019

Case-Control
Study

1000

Mortality Rate,
Hospital LOS,
Hospital Cost,
readmissions

III

B

2018

Quantitative
9,755
nonexperimental
study

Rate of
reduction of
HAPUs

III

B

Lam, C.,
Elkbuli, A.,
Benson, B.,
Young, E.,
Morejon, O.,
Boneva, D., …
Mckenney, M.
(2018).

Older patients with altered
consciousness are at
increased risk of PUs and
PU specific interventions
should be provided to
them regularly beginning
with admission
There was a discrepancy in
documentation of PUs on
physical exam and
progress notes. Missing
documentation on stages
and preventative
measures.
There is an increased rate
of mortality, LOS, Hospital
costs, readmissions in pts
with PUs.
There was a significant
rate of decrease in HAPU
incidence after process
changes were
implemented.
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Li, D. (2016)

Journal of
Clinical
Nursing

2016

Retrospective
comparative
descriptive
design

196

Documentation III
of PUs,
descriptive
factors,
treatment,
plan

B

There was no relationship
between documentation
quality and presence of
PU; but documentation on
PU lacked important
information on staging,
location, descriptive
factors, treatment
Study showed that a
multidisciplinary approach
effectively decreased rate
of HAPUs

Mallah, Z.,
Nassar, N., &
Kurdahi Badr,
L. (2015).

Applied
Nursing
Research

2015

Descriptive
Design

468

Rate of
prevalence of
HAPUs

III

B

Manzano, F.,
Pérez-Pérez,
A., MartínezRuiz, S.,
GarridoColmenero, C.,
Roldan, D.,
JiménezQuintana, M.,
… Colmenero,
M. (2014)
Padula, V.,
Gibbons, D.,
Valuck, J.,
Makic, B.,
Mishra, K.,
Pronovost, J.,
& Meltzer, O.
(2016).

Journal of
Evaluation in
Clinical
Practice

2014

Observational
study

563

Hospital
mortality

III

B

PU development increases
the mortality in patients
who require MV for 24
hours or longer

Wolters
Kluwer
health, Inc.

2016

Retrospectiveobservational
study

55

Rate of HAPUs

III

B

HAPU rates were
significantly lower after
CMS reimbursement
changes took effect. The
CMS changes influenced
adoption of EBPs for HAPU
prevention that led to the
reductions.
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Wang, S.,
Anderson, J.,
Evans, R.,
Woo, K.,
Breland, B.,
Sasseville, D.,
Moreau, L.
(2017).

PLos

2017

QuasiExperimental

87

Accurate
measurement
of PUs

II

B

Study showed that using a
wound measuring app
resulted in higher accuracy
than using ruler.
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Appendix E: AHRQ Staff Attitudes Survey
Your role: _____________________ Date: ___________________
Strongly
agree

Agree

Neither agree
Disagree Strongly disagree
nor disagree

1. All patients are at potential risk of
developing pressure ulcers
2. Pressure ulcer prevention is time
consuming for me to carry out
3. In my opinion, patients tend not to get
as many pressure ulcers nowadays

4. I do not need to concern myself with
pressure ulcer prevention in my practice

5. Pressure ulcer treatment is a greater
priority than pressure ulcer prevention
6. Continuous assessment of patients
will give an accurate account of their
pressure ulcer risk
7. Most pressure ulcers can be avoided
8. I am less interested in pressure ulcer
prevention than other aspects of care
9. My clinical judgment is better than
any pressure ulcer risk assessment tool
available to me
10. In comparison with other areas of
care, pressure ulcer prevention is a low
priority for me
11. Pressure ulcer risk assessment
should be regularly carried out on all
patients during their stay in hospital
AHRQ (2019). AHRQ Toolkit. Retrieved from
https://www.ahrq.gov/professionals/systems/hospital/pressureulcertoolkit/putool7a.html#Tool2H
Reference: Moore Z, Price P. Nurses' attitudes, behaviors, and perceived barriers towards pressure ulcer prevention. J Clin Nurs 2004;13:94252.

Implementing a Digital Imaging Protocol
63

Appendix F: Hospital Consent Form
GENERAL POLICY: All patients shall be treated, admitted and assigned accommodation without distinction to race, religion, color, national origin, sexual
orientation, age or handicapping condition.
CONSENT TO TREATMENT. I have come to The George Washington University Hospital for medical treatment. I ask the health care professionals at the
Hospital to provide care and treatment for me that they feel is necessary. The undersigned consents to the procedures, which may be performed during
this hospitalization, or on an outpatient basis including emergency treatment or services. I consent to undergo routine tests and treatment as part of
this care. These may include but are not limited to laboratory, radiology, medical or surgical tests, treatments, anesthesia or procedures as directed
under the general and special instruction of the physician or surgeon. I understand that I am free to ask a member of my health care team questions
about any care, treatment or medicine I am to receive. Because The George Washington University Hospital is a teaching hospital, I understand that my
health care team will be made up of hospital personnel (to include nurses, technicians, and ancillary staff) under the direction of my attending physician
and his/her assistants and designees (to include interns, residents, fellows and medical students). I am aware that the practice of medicine is not an
exact science and admit that no one has given me any promises or guarantees about the result of any care or treatment I am to receive or examinations
I am to undergo.
PHYSICIANS NOT AS EMPLOYEES: I understand that each physician is an independent contractor who is self employed and is not the agent, servant or
employee of the hospital. I understand that I may receive separate billing from each of these providers for services rendered.
Initials
RELEASE OF INFORMATION: The George Washington University Hospital is authorized to release any information necessary, including copies of my
hospital and medical records, to process payment claims for health care services which have been provided, and to duly authorized local and federal
regulatory agencies and accrediting bodies as required or permitted by law. George Washington University Hospital is further authorized to release
demographic information to organizations performing patient satisfaction surveys. Such records may include information of a psychological or psychiatric
nature, pertaining to my mental condition or treatment for conditions relating to the use of alcohol or drugs. In addition, I authorize my insurance carrier,
employer or person otherwise responsible for payment to provide The George Washington University Hospital information necessary to determine
benefits or process a claim. This release will be valid for the period of time to process the claim or until consent is revoked by myself. I release and forever
discharge The George Washington University Hospital, its employees and agents, and my attending physician from any liability resulting from the release
of my medical records or information from them for payment purposes. I understand that my name will be displayed in the signage system outside my
hospital room.

PERSONAL VALUABLES: THE GEORGE WASHINGTON UNIVERSITY HOSPITAL WILL NOT BE RESPONSIBLE FOR LOSS OR DAMAGE
TO CLOTHES, PERSONAL PROPERTY OR VALUABLES.
NON-SMOKING POLICY: In accordance with regulatory agency standards, the Hospital is a non-smoking facility.
FINANCIAL AGREEMENT/ASSIGNMENT OF BENEFITS: I assign any and all insurance benefits payable to me to The George Washington University Hospital.
I understand that I am responsible for payment for services rendered at the Hospital including excluded services from my insurance either because the
plan deems such services not medically necessary, or for any other reason including pre-certification requirements, second opinions or preexisting
conditions. Should the account be referred to any attorney or collection agency for collection, I understand that I will be responsible for attomey or
collection expenses. I give permission to my insurance provider(s), including Medicare and Medicaid, to directly pay The George Washington University
Hospital for my care instead of paying me. I understand that I am responsible for any health insurance deductibles and co-insurance and non-covered
services.
I certify that the information I have provided is true and accurate to the best of my knowledge. I understand that the information that I submit is subject
to verification, including credit agency scoring, and subject to review by federal and/or state agencies and other as required, I authorize my employer to
release to The George Washington University Hospital proof of my income. I understand that if any information I have given proves to be untrue, The
George Washington University Hospital will re-evaluate my financial status and take whatever action becomes appropriate. I acknowledge by my
signature that I have read and received a copy of this statement. I understand that by signing it, I am agreeing to it.

TO BE SIGNED AT THE HOSPITAL
Unable to sign
x

) Serious Condition
of patEnt or responsiNe party

Hospital RepresentativeDate

Section 1:
Did you bring an Advance Dlrectlve (Living Will/Heaith Care Power of Attorney) form with
you?
Yes

(If YES, place a copy in the front of the patients chart / If NO, go to Section
2)

By my signature below, I consent to laboratory studies (HIV, HBV,
HCV) in the event a health care worker is exposed to my blood or
body fluids. I consent to the appropriate disposal of any tissue or
part removed from my body and to the taking of photographs
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1.

I was given Information on formulating an Advance Directive

(including how to obtain assistance with completing the Advance Directive
form).

Inltlals

OR
2.
one.

during the procedure/operation/treatment for research, teaching,
or scientific purposes as long as my identity is not disclosed.

Signature

I do not have an Advance Directive and do not wish to formulate
Inltlals
Patient Label

THE
GEORGE
WASHINGTON
UNIVERSITY HOSPITAL
PATIENT AUTHORIZATION
FORM
C04000

80-010 (05/13)

Date
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Appendix G: Descriptive Statistics of Study Participants

Pre-Digital
Imaging

Post-Digital
Imaging

N=23
N(%)

N=32
N(%)

0
1 (4.3)
7 (30.4)
11 (47.8)
4 (17.4)
0

1 (3.1)
6 (18.8)
6 (18.8)
12 (37.5)
6 (18.8)
1 (3.1)

19 (82.6)
4 (17.4)

16 (50.0)
16 (50.0)

Hispanic
White, not Hispanic
Black, not Hispanic
Other, not Hispanic
Not reported or unknown

0
5 (21.7)
12 (52.2)
4 (17.3)
2 (8.7)

0
5 (15.6)
19 (59.4)
4 (12.5)
4 (12.5)

Clinical Condition (any
skin assessment on
admission)
POA diagnosis on admission
(POA)
Stage 1 ulcers
Stage 2 ulcers
Stage 3 ulcers
Stage 4 ulcers
Deep tissue injuries
Unstageable ulcers

1 (4.8)
1 (4.8)
1 (4.8)
1 (4.8)
5 (23.8)
6 (28.6)

0
0
6 (66.7)
0
0
0

6 (28.6)

3 (33.3)

Demographics

Statistics

Age
18-30
31-45
46-60
61-75
76-90
>91

Gender
Male
Female

Race/Ethnicity

No stage (Non-pressure
ulcers POA)
Total

21 (70.0)

9 (30.0)

Braden Score
Very high (9 or less)
High (10-12)
Moderate (13-14)
Mild (15-18)
No risk (19-23)

1 (7.1)
1 (7.1)
1 (7.1)
7 (50.0)
4 (28.6)

0
2 (7.4)
9 (33.3)
14 (51.9)
2 (7.4)

χ2(6) = 16.395, p = 0.003
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Documentation of
admission assessment
Yes
No

HAPUs
Stage 1 ulcers
Stage 2 ulcers
Stage 3 ulcers
Stage 4 ulcers
Deep tissue injuries
Unstageable ulcers
Other (Medical device
related mucosal pressure
injury)
Total

100%

100%

0
8 (29.6)
1 (3.7)
0
9 (33.3)
7 (25.9)
2 (7.4)

2 (4.4)
11 (24.4)
1 (2.2)
0
26 (57.8)
2 (4.4)
3 (6.7)

27 (37.5)

45 (62.5)

χ2(5) = 9.823, p = 0.059
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Appendix H: Variable Definition Table
Variables

Type of
Variable

Theoretical
Definition

Operational
Definition

POA (Present on
Admission)

Dependent

Abbreviation for
pressure ulcers that
are already present
on admission to the
hospital.

HAPUs (Hospital
Acquired Pressure
Ulcer)

Dependent

Abbreviation for
hospital acquired
pressure ulcers or
ulcers that occur
during hospital
admission.

Stage I ulcer

Independent

-Intact skin with nonblanchable redness of
a localized area
usually over a bony
prominence.
-Partial thickness Loss of dermis with a
shallow open ulcer,
red pink wound bed,
without slough.
-or intact or
open/ruptured serumfilled blister.

1= POA Stage 1 Nominal
ulcers
2= POA Stage 2
ulcers
3= POA Stage 3
ulcers
4= POA Stage 4
ulcers
5=POA Deep
tissue injuries
6=POA
Unstageable
ulcers
1= HA Stage 1
Nominal
ulcers
2= HA Stage 2
ulcers
3= HA Stage 3
ulcers
4= HA Stage 4
ulcers
5=HA Deep
tissue injuries
6=HA
Unstageable
ulcers
1=Stage I present Nominal

Stage 2 ulcer

Independent

Level of
measurement
(such as nominal,
ordinal, interval or
ratio

2=No stage I
1=Skin turgor

1=Stage 2
present
2=No stage 2

Nominal
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Stage 3 ulcer

Independent

-Full thickness tissue
loss.
-Subcutaneous fat may
be visible;
-No bone, tendon or
muscle is exposed.
-Slough may be
present but does not
obscure the depth or
tissue loss.
-May include
undermining and
tunneling.

1=Stage 3
present
2=No stage 3
present

Nominal

Stage 4 ulcer

Independent

-Full thickness tissue
loss
-Bone, tendon or
muscle is EXPOSED.
-Slough or eschar may
be present on some
parts of the wound
bed.
-Often include
undermining and
tunneling.

1=Stage 4
present
2=Stage 4 not
present

Nominal

Deep Tissue Injury Independent

-Purple/maroon
localized area of
discolored intact skin.
-Blood filled blister
due to damage of
underlying soft tissue
from pressure and/or
shear.
-Surrounding tissue
may be painful, firm,
mushy, boggy, warmer
or cooler as compared
to adjacent tissue.
-may be difficult to
detect in people with
darkly pigmented skin.

1=Deep Tissue
Injury present
2=Deep tissue
injury not
present

Nominal

Unstageable ulcer

-Full thickness tissue
loss in which the
wound bed is covered
by slough (yellow, tan,
gray, green or brown)
and /or eschar (tan,
brown or black) and

1=Unstageable
wound present
2=Unstageable
not present

Nominal

Independent
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depth and
measurements cannot
be done.
-therefore stage of the
wound cannot be
determined.
Software designed to
work with wound
photography IPODs
and integrate wound
information and
measurements into
Cerner
Staging of PU per
Digital Imaging
software

Tissue
Analytics/Digital
Imaging

Independent

If ulcer present,
what stage is it per
Digital Imaging
analyzation?

Dependent

Braden Scale

Independent

A tool that helps
assess a patient’s risk
for developing a
pressure ulcer

AHRQ Pressure
Ulcer tool

Independent
Dependent

Toolkit designed to
assist staff in
implementing
effective pressure
ulcer prevention
practices.

Variables from
Patient
Demographics
from Admission
documents

New software
integrated with
Cerner

1=Stage 1
2=Stage 2
3=Stage 3
4=Stage 4
5=Deep Tissue
Injury
6=Unstageable
1=very high risk
(score of 9 or
less).
2=High risk
(Total score of
10-12).
3=Moderate risk
(Total score of
13-14)
4=Mild risk
(Total score of
15-18)
5=No risk (Total
score of 19-23)

Nominal
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Age

Independent

Chronic age in years
of the patients

As recorded in
Medical
Records
1=18-30
2=31-45
3=46-60
4=61 -75
5=76-90
6= >91

Gender

Race/Ethnicity

Diagnosis

Independent/
Demographic

Patient’s biological
sex

0=male
1=female

Reported selfidentification with
the person or
population group
having shared
genetic or biological
traits

1=Hispanic
2=White, not
Hispanic
3=Black, not
Hispanic
4=Other, not
Hispanic
5=Not
reported
1= Stage 1
ulcers
2= Stage 2
ulcers
3= Stage 3
ulcers
4= Stage 4
ulcers
5=Deep tissue
injuries
6=Unstageable
ulcers
7=No ulcer
present

Stage of pressure
ulcer patient has
documented during
admission

Final Stage

Discharge Date

Discharge date
Notes

HAPU stage

HAPU Location

A-Day HAPU

Any HAPUs*?
1=Yes; 2=No

Stage of POA PU

PU Location

1=yes; 2=NO

Any POAs present

Wound Photography
completed/document
1=Yes; 2=No

Date of PU Admission
Assessment

PU Admission assessment
completed?
1=Yes;2=No

Ethnicity
1=Hispanic; 2=white(non Hisp);
3=black (non-Hisp); 4=other;
5=Not reported

Gender
1=Male;2=Female

Age cohort
1=18-30.9;2=31-45.9;3=4660.9;4=61 and more

Pt ID

Name

Admission Date
(month/day/year)
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Appendix I: Data Collection Table
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Appendix J: Data Codes
Patient ID code
Admission Date
Discharge Date
Medical Record Number
Age

Age cohort
1=18-30
2=31-45
3=46-60
4=61 -75
5=76-90
6= >91

Gender

1=Male
2=Female

Ethnicity

1=Hispanic
2=White, not Hispanic
3=Black, not Hispanic
4=Other, not Hispanic
5=Not reported
1=Yes
2=No

Admission Assessment completed

Date of PU Admission Assessment

(Month/Day/Year)

Pressure Ulcer Present on Admission
(POA)

1=Yes
2=No

If skin abnormality present on Admission
(POA), what stage is it?

1=Stage 1
2=Stage 2
3=Stage 3
4=Stage 4
5=Deep Tissue Injury (DTI)
6=Unstageable
7=No stage *for non PU skin abnormalities
1=Yes
2=No

Braden Scale completed?
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Wound Photography
completed/documented?

1=Very high risk: total score 9 or less
2=High risk: total score 10-12
3=Moderate risk: total score 13-14
4= Mild risk: total score 15-18
5=No risk: total score 18-23
1=Yes
2=No

Preventative Measures documented in
chart?

1=Yes
2=No

Hospital Acquired Ulcer (HAPU)

1=Yes
2=No

If HAPU present, what stage?

1=Stage 1
2=Stage 2
3=Stage 3
4=Stage 4
5=Deep Tissue Injury (DTI)
6=Unstageable
7=Medical Device Related (MDR)

Admission Day(s) that HAPU occurred

1= Days 1-3
2=Days 4-6
3=Days 7-10
4= Days 11-15
5=>15 days

Braden Score
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